Preventing ischemic stroke

PREVIEW

Since few patients are eligible to receive intravenous tissue plasminogen activator, the only approved treatment for acute stroke, prevention is the most important treatment strategy to reduce the burden of the disease. Numerous risk factors for stroke have been identified, and modification of these factors is the crux of primary prevention. In this article, Dr Ingall provides an overview of the data regarding the roles of both risk factor modification and medications in the primary and secondary prevention of ischemic stroke.